Literature DB >> 29090487

Influence of parameter accuracy on pharmacokinetic analysis of hyperpolarized pyruvate.

Chang-Yu Sun1, Christopher M Walker1,2, Keith A Michel1,2, Aradhana M Venkatesan3, Stephen Y Lai4, James A Bankson1,2.   

Abstract

PURPOSE: To explore the effects of noise and error on kinetic analyses of tumor metabolism using hyperpolarized [1-13 C] pyruvate.
METHODS: Numerical simulations were performed to systematically investigate the effects of noise, the number of unknowns, and error in kinetic parameter estimates on kinetic analysis of the apparent rate of chemical conversion from hyperpolarized pyruvate to lactate (kPL ). A pharmacokinetic model with two physical and two chemical pools of hyperpolarized spins was used to generate and analyze the synthetic data.
RESULTS: The reproducibility of kPL estimates worsened quickly when peak signal-to-noise ratio for hyperpolarized pyruvate was below approximately 20. The accuracy of kPL estimates was most sensitive to errors in high excitation angles, the vascular blood volume fraction (vb ), and the rate of pyruvate extravasation (kve ), and was least sensitive to errors in the T1 of pyruvate. When vb and/or kve were fit as additional unknowns, the accuracy of kPL estimates suffered, and when the vascular input function of pyruvate was also fit, the reproducibility of kPL estimates worsened.
CONCLUSIONS: The accuracy and precision of kPL estimates improve substantially for peak signal-to-noise ratio above approximately 20. Accurate estimates of perfusion parameters (combinations of vb , kve , and the pyruvate vascular input function) and transmit calibration at high excitation angles have the greatest effect on the accuracy of kinetic analyses. Magn Reson Med 79:3239-3248, 2018.
© 2017 International Society for Magnetic Resonance in Medicine. © 2017 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  dynamic nuclear polarization; hyperpolarized pyruvate; kinetic modeling; tumor metabolism

Mesh:

Substances:

Year:  2017        PMID: 29090487      PMCID: PMC5843516          DOI: 10.1002/mrm.26992

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  33 in total

1.  Kinetic modeling of hyperpolarized 13C1-pyruvate metabolism in normal rats and TRAMP mice.

Authors:  Matthew L Zierhut; Yi-Fen Yen; Albert P Chen; Robert Bok; Mark J Albers; Vickie Zhang; Jim Tropp; Ilwoo Park; Daniel B Vigneron; John Kurhanewicz; Ralph E Hurd; Sarah J Nelson
Journal:  J Magn Reson       Date:  2009-10-13       Impact factor: 2.229

2.  Hyperpolarized 13C MR spectroscopic imaging can be used to monitor Everolimus treatment in vivo in an orthotopic rodent model of glioblastoma.

Authors:  Myriam M Chaumeil; Tomoko Ozawa; IlWoo Park; Kristen Scott; C David James; Sarah J Nelson; Sabrina M Ronen
Journal:  Neuroimage       Date:  2011-07-23       Impact factor: 6.556

3.  Noninvasive detection of target modulation following phosphatidylinositol 3-kinase inhibition using hyperpolarized 13C magnetic resonance spectroscopy.

Authors:  Christopher S Ward; Humsa S Venkatesh; Myriam M Chaumeil; Alissa H Brandes; Mark Vancriekinge; Hagit Dafni; Subramaniam Sukumar; Sarah J Nelson; Daniel B Vigneron; John Kurhanewicz; C David James; Daphne A Haas-Kogan; Sabrina M Ronen
Journal:  Cancer Res       Date:  2010-02-09       Impact factor: 12.701

4.  Comparison of kinetic models for analysis of pyruvate-to-lactate exchange by hyperpolarized 13 C NMR.

Authors:  Crystal Harrison; Chendong Yang; Ashish Jindal; Ralph J DeBerardinis; M A Hooshyar; Matthew Merritt; A Dean Sherry; Craig R Malloy
Journal:  NMR Biomed       Date:  2012-03-26       Impact factor: 4.044

5.  Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy.

Authors:  Sam E Day; Mikko I Kettunen; Ferdia A Gallagher; De-En Hu; Mathilde Lerche; Jan Wolber; Klaes Golman; Jan Henrik Ardenkjaer-Larsen; Kevin M Brindle
Journal:  Nat Med       Date:  2007-10-28       Impact factor: 53.440

6.  MR Studies of Glioblastoma Models Treated with Dual PI3K/mTOR Inhibitor and Temozolomide:Metabolic Changes Are Associated with Enhanced Survival.

Authors:  Marina Radoul; Myriam M Chaumeil; Pia Eriksson; Alan S Wang; Joanna J Phillips; Sabrina M Ronen
Journal:  Mol Cancer Ther       Date:  2016-02-16       Impact factor: 6.261

7.  Glycolytic inhibition alters anaplastic thyroid carcinoma tumor metabolism and improves response to conventional chemotherapy and radiation.

Authors:  Vlad C Sandulache; Heath D Skinner; Yuan Wang; Yunyun Chen; Cristina T Dodge; Thomas J Ow; James A Bankson; Jeffrey N Myers; Stephen Y Lai
Journal:  Mol Cancer Ther       Date:  2012-05-09       Impact factor: 6.261

8.  Kinetic modeling of hyperpolarized (13)C pyruvate metabolism in tumors using a measured arterial input function.

Authors:  S M Kazan; S Reynolds; A Kennerley; E Wholey; J E Bluff; J Berwick; V J Cunningham; M N Paley; G M Tozer
Journal:  Magn Reson Med       Date:  2012-11-20       Impact factor: 4.668

9.  The cell cycle regulator 14-3-3σ opposes and reverses cancer metabolic reprogramming.

Authors:  Liem Phan; Ping-Chieh Chou; Guermarie Velazquez-Torres; Ismael Samudio; Kenneth Parreno; Yaling Huang; Chieh Tseng; Thuy Vu; Chris Gully; Chun-Hui Su; Edward Wang; Jian Chen; Hyun-Ho Choi; Enrique Fuentes-Mattei; Ji-Hyun Shin; Christine Shiang; Brian Grabiner; Marzenna Blonska; Stephen Skerl; Yiping Shao; Dianna Cody; Jorge Delacerda; Charles Kingsley; Douglas Webb; Colin Carlock; Zhongguo Zhou; Yun-Chih Hsieh; Jaehyuk Lee; Andrew Elliott; Marc Ramirez; Jim Bankson; John Hazle; Yongxing Wang; Lei Li; Shaofan Weng; Nibal Rizk; Yu Ye Wen; Xin Lin; Hua Wang; Huamin Wang; Aijun Zhang; Xuefeng Xia; Yun Wu; Mouhammed Habra; Wei Yang; Lajos Pusztai; Sai-Ching Yeung; Mong-Hong Lee
Journal:  Nat Commun       Date:  2015-07-16       Impact factor: 14.919

10.  Model free approach to kinetic analysis of real-time hyperpolarized 13C magnetic resonance spectroscopy data.

Authors:  Deborah K Hill; Matthew R Orton; Erika Mariotti; Jessica K R Boult; Rafal Panek; Maysam Jafar; Harold G Parkes; Yann Jamin; Maria Falck Miniotis; Nada M S Al-Saffar; Mounia Beloueche-Babari; Simon P Robinson; Martin O Leach; Yuen-Li Chung; Thomas R Eykyn
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

View more
  10 in total

1.  Correction and optimization of symmetric echo-planar spectroscopic imaging for hyperpolarized [1-13C]-pyruvate.

Authors:  Zhan Xu; Joshua S Niedzielski; Changyu Sun; Christopher M Walker; Keith A Michel; Samuel A Einstein; Gary V Martinez; James A Bankson
Journal:  J Magn Reson       Date:  2020-10-27       Impact factor: 2.229

2.  Kinetic Modeling of Hyperpolarized Carbon-13 Pyruvate Metabolism in the Human Brain.

Authors:  Daniele Mammoli; Jeremy Gordon; Adam Autry; Peder E Z Larson; Yan Li; Hsin-Yu Chen; Brian Chung; Peter Shin; Mark Van Criekinge; Lucas Carvajal; James B Slater; Robert Bok; Jason Crane; Duan Xu; Susan Chang; Daniel B Vigneron
Journal:  IEEE Trans Med Imaging       Date:  2019-07-02       Impact factor: 10.048

3.  Effects of excitation angle strategy on quantitative analysis of hyperpolarized pyruvate.

Authors:  Christopher M Walker; David Fuentes; Peder E Z Larson; Vikas Kundra; Daniel B Vigneron; James A Bankson
Journal:  Magn Reson Med       Date:  2019-02-22       Impact factor: 4.668

4.  A regional bolus tracking and real-time B1 calibration method for hyperpolarized 13 C MRI.

Authors:  Shuyu Tang; Eugene Milshteyn; Galen Reed; Jeremy Gordon; Robert Bok; Xucheng Zhu; Zihan Zhu; Daniel B Vigneron; Peder E Z Larson
Journal:  Magn Reson Med       Date:  2018-09-18       Impact factor: 4.668

5.  A variable resolution approach for improved acquisition of hyperpolarized 13 C metabolic MRI.

Authors:  Jeremy W Gordon; Adam W Autry; Shuyu Tang; Jasmine Y Graham; Robert A Bok; Xucheng Zhu; Javier E Villanueva-Meyer; Yan Li; Michael A Ohilger; Maria Roselle Abraham; Duan Xu; Daniel B Vigneron; Peder E Z Larson
Journal:  Magn Reson Med       Date:  2020-07-22       Impact factor: 4.668

6.  Hyperpolarized Pyruvate MR Spectroscopy Depicts Glycolytic Inhibition in a Mouse Model of Glioma.

Authors:  Keith A Michel; Rafal Zieliński; Christopher M Walker; Lucia Le Roux; Waldemar Priebe; James A Bankson; Dawid Schellingerhout
Journal:  Radiology       Date:  2019-08-06       Impact factor: 11.105

7.  Quantifying normal human brain metabolism using hyperpolarized [1-13C]pyruvate and magnetic resonance imaging.

Authors:  James T Grist; Mary A McLean; Frank Riemer; Rolf F Schulte; Surrin S Deen; Fulvio Zaccagna; Ramona Woitek; Charlie J Daniels; Joshua D Kaggie; Tomasz Matys; Ilse Patterson; Rhys Slough; Andrew B Gill; Anita Chhabra; Rose Eichenberger; Marie-Christine Laurent; Arnaud Comment; Jonathan H Gillard; Alasdair J Coles; Damian J Tyler; Ian Wilkinson; Bristi Basu; David J Lomas; Martin J Graves; Kevin M Brindle; Ferdia A Gallagher
Journal:  Neuroimage       Date:  2019-01-11       Impact factor: 6.556

Review 8.  Assessing Therapeutic Efficacy in Real-time by Hyperpolarized Magnetic Resonance Metabolic Imaging.

Authors:  Prasanta Dutta; Travis C Salzillo; Shivanand Pudakalakatti; Seth T Gammon; Benny A Kaipparettu; Florencia McAllister; Shawn Wagner; Daniel E Frigo; Christopher J Logothetis; Niki M Zacharias; Pratip K Bhattacharya
Journal:  Cells       Date:  2019-04-11       Impact factor: 6.600

Review 9.  Hyperpolarized Metabolic MRI-Acquisition, Reconstruction, and Analysis Methods.

Authors:  Peder Eric Zufall Larson; Jeremy W Gordon
Journal:  Metabolites       Date:  2021-06-14

10.  The effect of transmit B1 inhomogeneity on hyperpolarized [1-13 C]-pyruvate metabolic MR imaging biomarkers.

Authors:  Collin J Harlan; Zhan Xu; Christopher M Walker; Keith A Michel; Galen D Reed; James A Bankson
Journal:  Med Phys       Date:  2021-08-10       Impact factor: 4.506

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.